Novartis Trivalent Influenza Vaccine B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novartis Trivalent Influenza Vaccine B, covering 2014-11-03 to 2014-11-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age [Phase 3]